Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Hepatitis Australia
Listen
  • Search
  • Instagram
  • Twitter
  • Facebook
  • YouTube
Info line  Donate
Menu
  • About us
    • Who we are
    • Our Team
    • Our Board
    • Our Members
    • Corporate documents
    • Our website
    • Contacting Us
  • Hepatitis information
    • Liver Health
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis Statistics
    • Other Languages
  • How to get help
    • COVID-19
    • Hepatitis Infoline
    • Your Rights and Responsibilities
    • For friends and family
    • Local hepatitis organisations
  • Get involved
    • Donate
    • Share your story
  • Our work
    • Hepatitis B Program
    • Hepatitis C Program
    • Policy and Advocacy
    • Our publications
    • World Hepatitis Day
    • If tatts could talk
  • News
    • Latest News
    • Media Releases
  • Workforce
    • Community
    • Professionals
    • Training Opportunities
  • Admin
    • Log in
  • Basket: (0 items)
  1. About us
  2. Who we are

Who we are

Hepatitis Australia, incorporated in 1997, is the peak community organisation to progress national action on issues of importance to people affected by hepatitis B and hepatitis C. Our members are the eight state and territory hepatitis organisations.

Our Vision

To see an end to viral hepatitis in Australia.

Our Purpose

To enable and empower everyone in Australia to live free from the impact of viral hepatitis

Our Values

Central to the way we work are our core values:

  • We respect every individual impacted by viral hepatitis and promote their right to health.
  • We are diligent, determined and stand up for what we believe.
  • We use evidence to inform all of our work and strive for excellence.
  • We are accountable for our work and the responsible use of resources.

Our Role

We lead Australia’s community response to viral hepatitis by:

  • listening to, understanding and articulating the needs of people impacted by viral hepatitis
  • promoting public health policies and investment decisions that support the elimination of viral hepatitis
  • providing viral hepatitis information and education to improve health literacy and health outcomes
  • supporting our member organisations to deliver best practice programs at a local level
  • working collaboratively with our member organisations and national partners to drive required action.

Read our strategic plan


Page updated 3 July 2020

Published: 11th December, 2018

Updated: 3rd July, 2020

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Parliamentary Morning Tea: We can eliminate hepatitis C!

    Parliamentary Morning Tea: We can eliminate hepatitis C!

    The Parliamentary Friends Group for Action of Blood Borne Viruses Co-Chairs, Tim Wilson, MP and Senator Louise Pratt invite you to a Parliamentary Morning Tea on Thursday 12 November.

  • Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

    Renewed calls for Needle & Syringe Programs in prisons ahead of International Drug Users Day

    The Australian Injecting and Illicit Drug Users League (AIVL) and Hepatitis Australia are highlighting international calls for Needle and Syringe Programs (NSPs) in prisons, along with a greater focus on harm reduction initiatives, ahead of International Drug Users Day on 1 November.

  • Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

    Investment in hepatitis research needs to be accompanied by National Strategy implementation funding

    6 October 2020 - Hepatitis Australia welcomes the Australian Government’s commitment to diverse hepatitis research, however we remain concerned that the 2019 Health Budget funding for hepatitis commitments is yet to hit the ground.

  • Investment in liver cancer medicines matched with prevention are changing Australian lives

    Investment in liver cancer medicines matched with prevention are changing Australian lives

    6 October 2020 - Hepatitis Australia welcomes the Australian Government’s significant investment of $230 million to expand the listing of Tecentriq® and Avastin® (atezolizumab and bevacizumab) on the Pharmaceutical Benefits Scheme (PBS).

Most read

  • Coronavirus COVID-19 factsheet for people with hepatitis B and hepatitis C

    Coronavirus COVID-19 factsheet for people with hepatitis B and hepatitis C

    Hepatitis Australia has put together a brief factsheet with information about the coronavirus COVID-19 for people living with hepatitis B and hepatitis C.

  • COVID-19

    COVID-19

    Information on the coronavirus COVID-19 for people affected by hepatitis B or hepatitis C.

  • Hepatitis A

    Basic information about hepatitis A in Australia

  • A cure for hepatitis C

    A cure for hepatitis C

    New highly effective medicines are now available in Australia to cure hepatitis C

  • Hepatitis B and relationships

    Hepatitis B and relationships

    Although most people get hepatitis B at birth, it can be transmitted in other ways including sex. This article contains information about how it is spreads, and how you can keep your partner safe.

  • What is hepatitis C?

    What is hepatitis C?

    Basic information about hepatitis C and how it can effect you.

  • Hepatitis B treatment

    Hepatitis B treatment

    Who needs treatment for hepatitis B and what is involved.

  • What is hepatitis B?

    What is hepatitis B?

    Basic information about hepatitis B transmission and how it affects people.

  • Hepatitis B vaccination

    Hepatitis B vaccination

    Hepatitis B can be prevented with a safe and effective vaccine.

  • Accessibility

Join our mailing list

Interests

Info

Hepatitis Australia is a registered charity. 
ABN: 38 442 686 487

© Copyright 2019 Hepatitis Australia.
All rights reserved.
View our copyright statement here

Helpful links

  • Contact us
  • Full sitemap
  • Accessibillity
  • Terms & conditions
  • Privacy policy
  • Login
  • Logout
  • Manager

Member sites

  • Australian Capital Territory
  • New South Wales
  • Northern Territory
  • South Australia
  • Victoria
  • Queensland
  • Western Australia
  • Tasmania 

Information provided on this website is for general information only and not intended as medical advice. Hepatitis Australia encourages all readers to seek independent medical advice before making any decisions based on the information provided on this website.

Hepatitis Australia is a partner organisation of healthdirect Australia.
healthdirect - trusted health advice

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information: verify here.
Search only trustworthy HONcode health websites: 

Images used on this site may include stock photos and the associated messaging may not represent the personal situation, views or beliefs of the people in the images.